2018-2023 Global Metabolic Syndrome Market Report (Status and Outlook)

October 2018 | 133 pages | ID: 22E7D693C6EEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Metabolic Syndrome market for 2018-2023.
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes.
One of the upcoming trends gaining traction in the market is the increasing focus on oral insulin therapies. Till now, insulin injections were mostly administered through subcutaneous tissues, but this route of application is associated with risk of infection and hypersensitivity reactions, emboli, high cost, and injection site pain. Also, several needle-phobic individuals hesitate to adopt this route of administration. This paved the way for extensive research in the development of oral insulin. The oral form of insulin prevents the unpleasantness of insulin injections and other complications associated with the existing therapies. Moreover, oral administration of insulin ensures increased patient comfort and compliance, reduced risk of infection, simpler application, and is cost-effective.

Over the next five years, LPI(LP Information) projects that Metabolic Syndrome will register a 5.2% CAGR in terms of revenue, reach US$ 33400 million by 2023, from US$ 24600 million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Metabolic Syndrome market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Diabetes
• Obesity
• Lysosomal storage diseases

Segmentation by application:

• Hospital
• Clinic
• Others

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Novo Nordisk
• Sanofi
• Merck
• AstraZeneca
• Eli Lily
• AbbVie
• Actelion Pharmaceuticals
• Adocia
• Aegerion Pharmaceuticals
• Akros Pharma
• Alnylam Pharmaceuticals
• Amarin
• nAmgen
• Amicus Therapeutics
• Arbutus Biopharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Metabolic Syndrome market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Metabolic Syndrome market by identifying its various subsegments.
• Focuses on the key global Metabolic Syndrome players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Metabolic Syndrome with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Metabolic Syndrome submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL METABOLIC SYNDROME MARKET REPORT (STATUS AND OUTLOOK)

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Metabolic Syndrome Market Size 2013-2023
  2.1.2 Metabolic Syndrome Market Size CAGR by Region
2.2 Metabolic Syndrome Segment by Type
  2.2.1 Diabetes
  2.2.2 Obesity
  2.2.3 Hypercholesterolemia
  2.2.4 Lysosomal storage diseases
2.3 Metabolic Syndrome Market Size by Type
  2.3.1 Global Metabolic Syndrome Market Size Market Share by Type (2013-2018)
  2.3.2 Global Metabolic Syndrome Market Size Growth Rate by Type (2013-2018)
2.4 Metabolic Syndrome Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Metabolic Syndrome Market Size by Application
  2.5.1 Global Metabolic Syndrome Market Size Market Share by Application (2013-2018)
  2.5.2 Global Metabolic Syndrome Market Size Growth Rate by Application (2013-2018)

3 GLOBAL METABOLIC SYNDROME BY PLAYERS

3.1 Global Metabolic Syndrome Market Size Market Share by Players
  3.1.1 Global Metabolic Syndrome Market Size by Players (2016-2018)
  3.1.2 Global Metabolic Syndrome Market Size Market Share by Players (2016-2018)
3.2 Global Metabolic Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 METABOLIC SYNDROME BY REGIONS

4.1 Metabolic Syndrome Market Size by Regions
4.2 Americas Metabolic Syndrome Market Size Growth
4.3 APAC Metabolic Syndrome Market Size Growth
4.4 Europe Metabolic Syndrome Market Size Growth
4.5 Middle East & Africa Metabolic Syndrome Market Size Growth

5 AMERICAS

5.1 Americas Metabolic Syndrome Market Size by Countries
5.2 Americas Metabolic Syndrome Market Size by Type
5.3 Americas Metabolic Syndrome Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Metabolic Syndrome Market Size by Countries
6.2 APAC Metabolic Syndrome Market Size by Type
6.3 APAC Metabolic Syndrome Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Metabolic Syndrome by Countries
7.2 Europe Metabolic Syndrome Market Size by Type
7.3 Europe Metabolic Syndrome Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Metabolic Syndrome by Countries
8.2 Middle East & Africa Metabolic Syndrome Market Size by Type
8.3 Middle East & Africa Metabolic Syndrome Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL METABOLIC SYNDROME MARKET FORECAST

10.1 Global Metabolic Syndrome Market Size Forecast (2018-2023)
10.2 Global Metabolic Syndrome Forecast by Regions
  10.2.1 Global Metabolic Syndrome Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Metabolic Syndrome Forecast by Type
10.8 Global Metabolic Syndrome Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Novo Nordisk
  11.1.1 Company Details
  11.1.2 Metabolic Syndrome Product Offered
  11.1.3 Novo Nordisk Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Novo Nordisk News
11.2 Sanofi
  11.2.1 Company Details
  11.2.2 Metabolic Syndrome Product Offered
  11.2.3 Sanofi Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Sanofi News
11.3 Merck
  11.3.1 Company Details
  11.3.2 Metabolic Syndrome Product Offered
  11.3.3 Merck Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Merck News
11.4 AstraZeneca
  11.4.1 Company Details
  11.4.2 Metabolic Syndrome Product Offered
  11.4.3 AstraZeneca Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 AstraZeneca News
11.5 Eli Lily
  11.5.1 Company Details
  11.5.2 Metabolic Syndrome Product Offered
  11.5.3 Eli Lily Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Eli Lily News
11.6 AbbVie
  11.6.1 Company Details
  11.6.2 Metabolic Syndrome Product Offered
  11.6.3 AbbVie Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 AbbVie News
11.7 Actelion Pharmaceuticals
  11.7.1 Company Details
  11.7.2 Metabolic Syndrome Product Offered
  11.7.3 Actelion Pharmaceuticals Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Actelion Pharmaceuticals News
11.8 Adocia
  11.8.1 Company Details
  11.8.2 Metabolic Syndrome Product Offered
  11.8.3 Adocia Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Adocia News
11.9 Aegerion Pharmaceuticals
  11.9.1 Company Details
  11.9.2 Metabolic Syndrome Product Offered
  11.9.3 Aegerion Pharmaceuticals Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Aegerion Pharmaceuticals News
11.10 Akros Pharma
  11.10.1 Company Details
  11.10.2 Metabolic Syndrome Product Offered
  11.10.3 Akros Pharma Metabolic Syndrome Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Akros Pharma News
11.11 Alnylam Pharmaceuticals
11.12 Amarin
11.13 nAmgen
11.14 Amicus Therapeutics
11.15 Arbutus Biopharma

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Metabolic Syndrome
Figure Metabolic Syndrome Report Years Considered
Figure Market Research Methodology
Figure Global Metabolic Syndrome Market Size Growth Rate 2013-2023 ($ Millions)
Table Metabolic Syndrome Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Diabetes
Table Major Players of Obesity
Table Major Players of Hypercholesterolemia
Table Major Players of Lysosomal storage diseases
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Metabolic Syndrome Market Size Market Share by Type (2013-2018)
Figure Global Metabolic Syndrome Market Size Market Share by Type (2013-2018)
Figure Global Diabetes Market Size Growth Rate
Figure Global Obesity Market Size Growth Rate
Figure Global Hypercholesterolemia Market Size Growth Rate
Figure Global Lysosomal storage diseases Market Size Growth Rate
Figure Metabolic Syndrome Consumed in Hospital
Figure Global Metabolic Syndrome Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Metabolic Syndrome Consumed in Clinic
Figure Global Metabolic Syndrome Market: Clinic (2013-2018) ($ Millions)
Figure Global Clinic YoY Growth ($ Millions)
Figure Metabolic Syndrome Consumed in Others
Figure Global Metabolic Syndrome Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Metabolic Syndrome Market Size by Application (2013-2018) ($ Millions)
Table Global Metabolic Syndrome Market Size Market Share by Application (2013-2018)
Figure Global Metabolic Syndrome Market Size Market Share by Application (2013-2018)
Figure Global Metabolic Syndrome Market Size in Hospital Growth Rate
Figure Global Metabolic Syndrome Market Size in Clinic Growth Rate
Figure Global Metabolic Syndrome Market Size in Others Growth Rate
Table Global Metabolic Syndrome Revenue by Players (2016-2018) ($ Millions)
Table Global Metabolic Syndrome Revenue Market Share by Players (2016-2018)
Figure Global Metabolic Syndrome Revenue Market Share by Players in 2017
Table Global Metabolic Syndrome Key Players Head office and Products Offered
Table Metabolic Syndrome Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Metabolic Syndrome Market Size by Regions 2013-2018 ($ Millions)
Table Global Metabolic Syndrome Market Size Market Share by Regions 2013-2018
Figure Global Metabolic Syndrome Market Size Market Share by Regions 2013-2018
Figure Americas Metabolic Syndrome Market Size 2013-2018 ($ Millions)
Figure APAC Metabolic Syndrome Market Size 2013-2018 ($ Millions)
Figure Europe Metabolic Syndrome Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Metabolic Syndrome Market Size 2013-2018 ($ Millions)
Table Americas Metabolic Syndrome Market Size by Countries (2013-2018) ($ Millions)
Table Americas Metabolic Syndrome Market Size Market Share by Countries (2013-2018)
Figure Americas Metabolic Syndrome Market Size Market Share by Countries in 2017
Table Americas Metabolic Syndrome Market Size by Type (2013-2018) ($ Millions)
Table Americas Metabolic Syndrome Market Size Market Share by Type (2013-2018)
Figure Americas Metabolic Syndrome Market Size Market Share by Type in 2017
Table Americas Metabolic Syndrome Market Size by Application (2013-2018) ($ Millions)
Table Americas Metabolic Syndrome Market Size Market Share by Application (2013-2018)
Figure Americas Metabolic Syndrome Market Size Market Share by Application in 2017
Figure United States Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure Canada Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Table APAC Metabolic Syndrome Market Size by Countries (2013-2018) ($ Millions)
Table APAC Metabolic Syndrome Market Size Market Share by Countries (2013-2018)
Figure APAC Metabolic Syndrome Market Size Market Share by Countries in 2017
Table APAC Metabolic Syndrome Market Size by Type (2013-2018) ($ Millions)
Table APAC Metabolic Syndrome Market Size Market Share by Type (2013-2018)
Figure APAC Metabolic Syndrome Market Size Market Share by Type in 2017
Table APAC Metabolic Syndrome Market Size by Application (2013-2018) ($ Millions)
Table APAC Metabolic Syndrome Market Size Market Share by Application (2013-2018)
Figure APAC Metabolic Syndrome Market Size Market Share by Application in 2017
Figure China Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure Japan Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure Korea Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure India Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure Australia Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Table Europe Metabolic Syndrome Market Size by Countries (2013-2018) ($ Millions)
Table Europe Metabolic Syndrome Market Size Market Share by Countries (2013-2018)
Figure Europe Metabolic Syndrome Market Size Market Share by Countries in 2017
Table Europe Metabolic Syndrome Market Size by Type (2013-2018) ($ Millions)
Table Europe Metabolic Syndrome Market Size Market Share by Type (2013-2018)
Figure Europe Metabolic Syndrome Market Size Market Share by Type in 2017
Table Europe Metabolic Syndrome Market Size by Application (2013-2018) ($ Millions)
Table Europe Metabolic Syndrome Market Size Market Share by Application (2013-2018)
Figure Europe Metabolic Syndrome Market Size Market Share by Application in 2017
Figure Germany Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure France Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure UK Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure Italy Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure Russia Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure Spain Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Metabolic Syndrome Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Metabolic Syndrome Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Metabolic Syndrome Market Size Market Share by Countries in 2017
Table Middle East & Africa Metabolic Syndrome Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Metabolic Syndrome Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Metabolic Syndrome Market Size Market Share by Type in 2017
Table Middle East & Africa Metabolic Syndrome Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Metabolic Syndrome Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Metabolic Syndrome Market Size Market Share by Application in 2017
Figure Egypt Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure Israel Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Metabolic Syndrome Market Size Growth 2013-2018 ($ Millions)
Figure Global Metabolic Syndrome arket Size Forecast (2018-2023) ($ Millions)
Table Global Metabolic Syndrome Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Metabolic Syndrome Market Size Market Share Forecast by Regions
Figure Americas Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure APAC Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Europe Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure United States Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Canada Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Mexico Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Brazil Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure China Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Japan Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Korea Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure India Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Australia Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Germany Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure France Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure UK Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Italy Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Russia Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Spain Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Egypt Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure South Africa Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Israel Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure Turkey Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Figure GCC Countries Metabolic Syndrome Market Size 2018-2023 ($ Millions)
Table Global Metabolic Syndrome Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Metabolic Syndrome Market Size Market Share Forecast by Type (2018-2023)
Table Global Metabolic Syndrome Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Metabolic Syndrome Market Size Market Share Forecast by Application (2018-2023)
Table Novo Nordisk Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novo Nordisk Metabolic Syndrome Revenue and Gross Margin (2016-2018)
Figure Novo Nordisk Metabolic Syndrome Market Share (2016-2018)
Table Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sanofi Metabolic Syndrome Revenue and Gross Margin (2016-2018)
Figure Sanofi Metabolic Syndrome Market Share (2016-2018)
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Metabolic Syndrome Revenue and Gross Margin (2016-2018)
Figure Merck Metabolic Syndrome Market Share (2016-2018)
Table AstraZeneca Basic Information, Head Office, Major Market Areas and Its Competitors
Table AstraZeneca Metabolic Syndrome Revenue and Gross Margin (2016-2018)
Figure AstraZeneca Metabolic Syndrome Market Share (2016-2018)
Table Eli Lily Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lily Metabolic Syndrome Revenue and Gross Margin (2016-2018)
Figure Eli Lily Metabolic Syndrome Market Share (2016-2018)
Table AbbVie Basic Information, Head Office, Major Market Areas and Its Competitors
Table AbbVie Metabolic Syndrome Revenue and Gross Margin (2016-2018)
Figure AbbVie Metabolic Syndrome Market Share (2016-2018)
Table Actelion Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Actelion Pharmaceuticals Metabolic Syndrome Revenue and Gross Margin (2016-2018)
Figure Actelion Pharmaceuticals Metabolic Syndrome Market Share (2016-2018)
Table Adocia Basic Information, Head Office, Major Market Areas and Its Competitors
Table Adocia Metabolic Syndrome Revenue and Gross Margin (2016-2018)
Figure Adocia Metabolic Syndrome Market Share (2016-2018)
Table Aegerion Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Aegerion Pharmaceuticals Metabolic Syndrome Revenue and Gross Margin (2016-2018)
Figure Aegerion Pharmaceuticals Metabolic Syndrome Market Share (2016-2018)
Table Akros Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Akros Pharma Metabolic Syndrome Revenue and Gross Margin (2016-2018)
Figure Akros Pharma Metabolic Syndrome Market Share (2016-2018)
Table Alnylam Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amarin Basic Information, Head Office, Major Market Areas and Its Competitors
Table nAmgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amicus Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Arbutus Biopharma Basic Information, Head Office, Major Market Areas and Its Competitors